FDA.reportPublic FDA data

Retrovir 100 MG Oral Capsule

RxCUI
201907
RxNorm name
Retrovir 100 MG Oral Capsule
Display name
Retrovir 100 MG Oral Capsule
Full name
Retrovir 100 MG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RETROVIRZIDOVUDINEViiV Healthcare Company6df09f15-b102-431c-adde-d7aeef6f5d842024-11-13Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 201907

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6df09f15-b102-431c-adde-d7aeef6f5d84RETROVIR 100 MG Oral Capsule [PSN] · zidovudine 100 MG Oral Capsule [Retrovir] [SBD] · AZT 100 MG Oral Capsule [Retrovir] [SY] · Retrovir 100 MG Oral Capsule [SY]432These highlights do not include all the information needed to use RETROVIR safely and effectively. See full prescribing information for RETROVIR. RETROVIR (zidovudine) capsules, for oral use RETROVIR (zidovudine) oral solution RETROVIR (zidovudine) injection, for intravenous use Initial U.S. Approval: 198720241113